-Litigation arising out of the recent Stryker Hip Recall is moving forward in a consolidated proceeding based in the New Jersey Superior Court.  An initial conference has been scheduled for February 20th, 2013 at 10:00 am.

-Stryker announced the recall of its Rejuvenate and ABG II modular neck-stem on July 6, 2010.  The recall was based on the potential for fretting and corrosion at the junction of the modular and neck.  Symptoms included  pain, swelling, tissue death and the need for a revision.  The Rejuvenate stem was approved in June 2008 by the FDA as an extension to Stryker’s Modular Hip System Product Line.  It was approved through the FDA’s 510(k) Premarket Notification Process, which allowed it to circumvent certain testing.

-The Stryker Rejuvenate hip implant has been linked to an increased risk of metallosis, high early failure rate, and ultimately replacement of the device.  Even without a metal ball like other metal-on-metal implants, metallosis is caused by the metal neck piece rubbing against a metal stem, causing the metallic debris to come loose.  Metallosis is an adverse tissue reaction to heavy metals in the body.  This reaction can cause pain, restricted mobility, pseudo-tumors, bone dissolution, and failure of the hip joint.

-Please contact the Gomez Iagmin Trial Attorneys today to protect your legal rights.